231 related articles for article (PubMed ID: 24064975)
1. Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.
Posthumadeboer J; Piersma SR; Pham TV; van Egmond PW; Knol JC; Cleton-Jansen AM; van Geer MA; van Beusechem VW; Kaspers GJ; van Royen BJ; Jiménez CR; Helder MN
Br J Cancer; 2013 Oct; 109(8):2142-54. PubMed ID: 24064975
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.
Zhang Z; Zhang L; Hua Y; Jia X; Li J; Hu S; Peng X; Yang P; Sun M; Ma F; Cai Z
BMC Cancer; 2010 May; 10():206. PubMed ID: 20470422
[TBL] [Abstract][Full Text] [Related]
3. Plasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcoma.
Hua Y; Jia X; Sun M; Zheng L; Yin L; Zhang L; Cai Z
Tumour Biol; 2011 Oct; 32(5):1013-21. PubMed ID: 21706236
[TBL] [Abstract][Full Text] [Related]
4. [Effect of EPHA2-siRNA plasmid on biological behavior of human osteosarcoma cells in vitro].
Zhang LZ; Cai XS; Qian ZK; Mei J; Ma XH; Huang HY; Huang WD
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):566-9. PubMed ID: 18210872
[TBL] [Abstract][Full Text] [Related]
5. Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.
Posthumadeboer J; van Egmond PW; Helder MN; de Menezes RX; Cleton-Jansen AM; Beliën JA; Verheul HM; van Royen BJ; Kaspers GJ; van Beusechem VW
Oncotarget; 2012 Oct; 3(10):1169-81. PubMed ID: 23045411
[TBL] [Abstract][Full Text] [Related]
6. De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway.
Fritsche-Guenther R; Noske A; Ungethüm U; Kuban RJ; Schlag PM; Tunn PU; Karle J; Krenn V; Dietel M; Sers C
Histopathology; 2010 Dec; 57(6):836-50. PubMed ID: 21166698
[TBL] [Abstract][Full Text] [Related]
7. EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Nazmi K; De Boer JP; Zandieh-Doulabi B; Forouzanfar T; Helder MN
Pharm Res; 2017 Dec; 34(12):2891-2900. PubMed ID: 29110283
[TBL] [Abstract][Full Text] [Related]
8. EphA2 is a biomarker of hMSCs derived from human placenta and umbilical cord.
Shen SP; Liu WT; Lin Y; Li YT; Chang CH; Chang FW; Wang LM; Teng SW; Hsuan Y
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):749-56. PubMed ID: 26700997
[TBL] [Abstract][Full Text] [Related]
9. EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapy.
Wang Z; He Z; Wan J; Chen A; Cheng P; Zhu W
J Nanobiotechnology; 2024 Mar; 22(1):89. PubMed ID: 38433190
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours.
Hsu K; Middlemiss S; Saletta F; Gottschalk S; McCowage GB; Kramer B
Cancer Gene Ther; 2021 Apr; 28(3-4):321-334. PubMed ID: 32873870
[TBL] [Abstract][Full Text] [Related]
11. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
Lu B; Feng Z; Fan B; Shi Y
Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
Milovancev M; Hilgart-Martiszus I; McNamara MJ; Goodall CP; Seguin B; Bracha S; Wickramasekara SI
BMC Vet Res; 2013 Jun; 9():116. PubMed ID: 23758893
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.
Ståhl S; Branca RM; Efazat G; Ruzzene M; Zhivotovsky B; Lewensohn R; Viktorsson K; Lehtiö J
J Proteome Res; 2011 May; 10(5):2566-78. PubMed ID: 21413766
[TBL] [Abstract][Full Text] [Related]
16. Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells.
Gemei M; Corbo C; D'Alessio F; Di Noto R; Vento R; Del Vecchio L
Proteomics; 2013 Nov; 13(22):3293-7. PubMed ID: 24106197
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
[TBL] [Abstract][Full Text] [Related]
18. Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.
Patel P; Hardy R; Sumathi V; Bartle G; Kindblom LG; Grimer R; Bujalska I; Stewart PM; Rabbitt E; Gittoes NJ; Cooper MS
Endocr Relat Cancer; 2012 Aug; 19(4):589-98. PubMed ID: 22719058
[TBL] [Abstract][Full Text] [Related]
19. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
20. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
